drugset / Trial / NCT00675948
Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
Non-randomizedSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to assess the safety and tolerability of long term therapy with Sativex® and GW-2000-02.
Timeline
- Start
- 2002-04
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW-2000-02 | Unknown | 130 mg | Other |
| Subject | Nabiximols | Other / unclassified | 120 mg | Other |
| Subject | Nabiximols | Other / unclassified | 130 mg | Other |